Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. (Q47349499)

14 January 2018

title

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. (English)

1 reference

14 January 2018

0 references

Milla Koistinaho

1

1 reference

14 January 2018

Suizhen Lin

2

1 reference

14 January 2018

Xin Wu

3

1 reference

14 January 2018

Michail Esterman

4

1 reference

14 January 2018

Deanna Koger

5

1 reference

14 January 2018

Jeffrey Hanson

6

1 reference

14 January 2018

Richard Higgs

7

1 reference

14 January 2018

Feng Liu

8

1 reference

14 January 2018

Seema Malkani

9

1 reference

14 January 2018

Kelly R Bales

10

1 reference

14 January 2018

Steven M Paul

11

1 reference

14 January 2018

language of work or name

English

0 references

publication date

13 June 2004

1 reference

14 January 2018

published in

Nature Medicine

1 reference

14 January 2018

volume

10

1 reference

14 January 2018

page(s)

719-726

1 reference

14 January 2018

issue

7

1 reference

14 January 2018

https://scigraph.springernature.com/pub.10.1038/nm1058

exact match

0 references

cites work

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

7 January 2021

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

1 reference

7 January 2021

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

1 reference

7 January 2021

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

7 January 2021

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

1 reference

7 January 2021

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

1 reference

7 January 2021

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease

1 reference

7 January 2021

Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease.

1 reference

7 January 2021

TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

1 reference

7 January 2021

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

7 January 2021

Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.

1 reference

7 January 2021

Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils.

1 reference

7 January 2021

Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide

1 reference

7 January 2021

Ultrastructural studies of the cells forming amyloid fibers in classical plaques.

1 reference

7 January 2021

The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice.

1 reference

7 January 2021

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

7 January 2021

Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia.

1 reference

7 January 2021

Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species.

1 reference

7 January 2021

Plasticity of astrocytes

1 reference

7 January 2021

Astrocytes: form, functions, and roles in disease

1 reference

7 January 2021

Astroglia in CNS injury

1 reference

7 January 2021

Apolipoprotein E and low-density lipoprotein binding and internalization in primary cultures of rat astrocytes: isoform-specific alterations

1 reference

7 January 2021

Specific uptake of Aβ1-40 in rat brain occurs in astrocyte, but not in microglia

1 reference

7 January 2021

Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation

1 reference

7 January 2021

Adult mouse astrocytes degrade amyloid-beta in vitro and in situ

1 reference

7 January 2021

39-kD protein inhibits tissue-type plasminogen activator clearance in vivo

1 reference

7 January 2021

Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-beta protein into synaptic terminals

1 reference

7 January 2021

Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex.

1 reference

7 January 2021

Diffuse plaques associated with astroglial amyloid beta protein, possibly showing a disappearing stage of senile plaques.

1 reference

7 January 2021

Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization.

1 reference

7 January 2021

Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide

1 reference

7 January 2021

Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1058

1 reference

14 January 2018

release_hiq33yjs2vfztilpdt5qsdtkaq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hiq33yjs2vfztilpdt5qsdtkaq

24 November 2022

mapped directly with Wikidata item

PubMed ID

15195085

1 reference

14 January 2018